Movatterモバイル変換


[0]ホーム

URL:


Eurekaselect logo
Bentham Newsletternewsletter banner
Login
Login

Forgot Your Password? New around here? Sign up
Register Cart 0
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Search for Distinctive Markers in DNT and Cortical Grade II Glioma in Children: Same Clinicopathological and Molecular Entities?

Author(s): Laetitia Padovani, Carole Colin, Carla Fernandez, Andre Maues de Paula, Sandy Mercurio, Didier Scavarda, Frederic Frassineti, Jose Adelaide, Anderson Loundou, Dominique Intagliata, Corinne Bouvier, Gabriel Lena, Daniel Birnbaum, Nadine Girard andDominique Figarella-Branger

Volume 12, Issue 15, 2012

Page: [1683 - 1692]Pages: 10

DOI:10.2174/156802612803531450

Price: $65

TIMBC 2025
Abstract

Background: Dysembryoplastic Neuroepithelial Tumours (DNT) are benign brain lesions arising during childhoodthat are characterized by early onset partial seizures, no neurological deficit and cortical location. Pathological diagnosisis easy when the glioneuronal element is present. Its absence might lead to the diagnosis of non-specific DNT orlow-grade glioma (LGG).

Objective: The aim of this retrospective study was to analyse clinicopathological and molecular features of a series of corticaltumours, in order to find diagnostic and prognostic markers to better custom treatment next.

Methods: Twenty four children with cortical neuroepithelial tumour were included. Clinical and radiological data werecollected. Histological diagnosis was reviewed for all patients. 1p19q and p53 status were obtained by FISH and immunohistochemistryrespectively. IDH1-2 gene mutations were assessed by DNA sequencing. CGH-array was performed in6/24 samples.

Results: We recorded 13 DNT and 11 cortical LGG. Median age at surgery was 11.5 years. Overall survival was 100%and event-free survival at 10 years was 70%. No tumour displayed chromosomal alteration or 1p19q deletion or p53 expression.Only one patient with grade-II oligoastrocytoma had an IDH1 mutation. No statistical difference was found betweenthe two populations in terms of age, sex, tumour location, type of surgical resection, disease progression and clinicalstatus at last follow-up. Only the occurrence of septations on preoperative MRI was significantly associated withpathological features of DNT.

Conclusion: Patients with DNT and cortical LGG share excellent outcome. Our genetic analysis could not distinguishDNT from LGG. In particular, CGH-array analysis was strictly normal in both tumor types. In attempt to find molecularmarkers, diagnosis of these lesions remains difficult when the glioneuronal element is lacking.

Keywords:Biological and genetic markers, Dysembryoplasic Neuroepithelial Tumours (DNT), IDH1 gene, low grade glioma,glioneuronal element


Rights & PermissionsPrintCite

Current Topics in Medicinal Chemistry

Title:Search for Distinctive Markers in DNT and Cortical Grade II Glioma in Children: Same Clinicopathological and Molecular Entities?

Volume: 12Issue: 15

Author(s):Laetitia Padovani, Carole Colin, Carla Fernandez, Andre Maues de Paula, Sandy Mercurio, Didier Scavarda, Frederic Frassineti, Jose Adelaide, Anderson Loundou, Dominique Intagliata, Corinne Bouvier, Gabriel Lena, Daniel Birnbaum, Nadine Girard and Dominique Figarella-Branger

Affiliation:

                                Keywords:Biological and genetic markers, Dysembryoplasic Neuroepithelial Tumours (DNT), IDH1 gene, low grade glioma,glioneuronal element

                                Abstract: Background: Dysembryoplastic Neuroepithelial Tumours (DNT) are benign brain lesions arising during childhoodthat are characterized by early onset partial seizures, no neurological deficit and cortical location. Pathological diagnosisis easy when the glioneuronal element is present. Its absence might lead to the diagnosis of non-specific DNT orlow-grade glioma (LGG).

                                Objective: The aim of this retrospective study was to analyse clinicopathological and molecular features of a series of corticaltumours, in order to find diagnostic and prognostic markers to better custom treatment next.

                                Methods: Twenty four children with cortical neuroepithelial tumour were included. Clinical and radiological data werecollected. Histological diagnosis was reviewed for all patients. 1p19q and p53 status were obtained by FISH and immunohistochemistryrespectively. IDH1-2 gene mutations were assessed by DNA sequencing. CGH-array was performed in6/24 samples.

                                Results: We recorded 13 DNT and 11 cortical LGG. Median age at surgery was 11.5 years. Overall survival was 100%and event-free survival at 10 years was 70%. No tumour displayed chromosomal alteration or 1p19q deletion or p53 expression.Only one patient with grade-II oligoastrocytoma had an IDH1 mutation. No statistical difference was found betweenthe two populations in terms of age, sex, tumour location, type of surgical resection, disease progression and clinicalstatus at last follow-up. Only the occurrence of septations on preoperative MRI was significantly associated withpathological features of DNT.

                                Conclusion: Patients with DNT and cortical LGG share excellent outcome. Our genetic analysis could not distinguishDNT from LGG. In particular, CGH-array analysis was strictly normal in both tumor types. In attempt to find molecularmarkers, diagnosis of these lesions remains difficult when the glioneuronal element is lacking.

                                Export Options

                                About this article

                                Cite this article as:

                                Padovani Laetitia, Colin Carole, Fernandez Carla, Maues de Paula Andre, Mercurio Sandy, Scavarda Didier, Frassineti Frederic, Adelaide Jose, Loundou Anderson, Intagliata Dominique, Bouvier Corinne, Lena Gabriel, Birnbaum Daniel, Girard Nadine and Figarella-Branger Dominique, Search for Distinctive Markers in DNT and Cortical Grade II Glioma in Children: Same Clinicopathological and Molecular Entities?, Current Topics in Medicinal Chemistry 2012; 12 (15) .https://dx.doi.org/10.2174/156802612803531450

                                DOI
                                https://dx.doi.org/10.2174/156802612803531450
                                Print ISSN
                                1568-0266
                                Publisher Name
                                Bentham Science Publisher
                                Online ISSN
                                1873-4294

                                Call for Papers in Thematic Issues

                                31 December, 2025
                                Adaptogens—History and Future Perspectives

                                Adaptogens are pharmacologically active compounds or plant extracts that are associated with the ability to enhance the body’s stability against stress. The intake of adaptogens is associated not only with a better ability to adapt to stress and maintain or normalise metabolic functions but also with better mental and physical ...read more


                                Guest Editor(s):Dr. Drozdstoy Stoyanov
                                08 January, 2026
                                Addressing the Most Common Causes of Death with Niacin/NAD and Inositol Polyphosphates

                                The most common causes of death in the world are cardiovascular disease (CVD) and cancer. These are perhaps best addressed by reducing lipodystrophy and blockages with niacin and inositol polyphosphates (e.g., IP6+inositol) respectively when addressing CVD. Niacin serves as a vitamin by virtue of its role as a skeletal precursor ...read more


                                Guest Editor(s): Dr. William Todd Penberthy
                                31 December, 2025
                                AlphaFold in Medicinal Chemistry: Opportunities and Challenges

                                AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more


                                Guest Editor(s):Dr. Jun Chen
                                31 December, 2025
                                Artificial intelligence for Natural Products Discovery and Development

                                Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more


                                Guest Editor(s):Dr. Lianxiang Luo
                                Related Journals

                                Anti-Cancer Agents in Medicinal Chemistry

                                Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

                                Current Bioactive Compounds

                                Current Cancer Drug Targets

                                Combinatorial Chemistry & High Throughput Screening

                                Current Cancer Therapy Reviews

                                Current Diabetes Reviews

                                Current Drug Safety

                                Current Drug Targets

                                Current Drug Therapy

                                Related Books

                                Andrographolide and its Analogs: Botanical Sources, Phytochemistry, Pharmacology, and Biotechnology

                                Metabolites of Medicinal Plants: Insightful Approaches

                                Herbs for Disease Prevention and Treatment

                                Anthocyanins: Pharmacology and Nutraceutical Importance

                                Herbal Medicine for Autoimmune Diseases

                                Therapeutic Insights into Herbal Medicine through the Use of Phytomolecules

                                The Roles and Responsibilities of Clinical Pharmacists in Hospital Settings

                                Bioactive Compounds from Medicinal Plants for Cancer Therapy and Chemoprevention

                                Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies

                                The Chemistry inside Spices & Herbs: Research and Development

                                Article Metrics
                                19
                                Wayfinder Image
                                TIMBC 2025
                                Related Articles
                                © 2025 Bentham Science Publishers |Privacy Policy

                                [8]ページ先頭

                                ©2009-2025 Movatter.jp